This audit reviews the appropriate use of aspirin as per national guidelines.
This audit aims to ensure that the budget invested in the NHS D&G Joint Formulary calcium channel blockers (CCBs) for the management of hypertension and angina is cost effective and rational.
The aim of this audit is to review patients diagnosed with hypertension in the past 6 months to ensure treatment is prescribed as per the NICE clinical guideline 127.
This audit protocol supports the review of patients who are taking Dipyridamole MR for the secondary prevention of occlusive events following ischaemic stroke, TIA or amaurosis fugax.
Diltiazem is available as a number of modified release products. In NHS D&G the formulary options are Zemtard XL and Angitil SR capsules. This review aims to increase formulary complaince with these products.
This audit supports evidence based prescribing in line with NHS D & G joint formualry 2011 for the purpose of treating patients with hypertension intolerant of ACE inhibitors.